[Photo] Yuhan-Kimberly, First in Korea to Obtain Pharmaceutical Quasi-Drug GMP Certification

On the 1st, employees at Yuhan-Kimberly's Chungju plant production line posed to celebrate obtaining the quasi-drug GMP certification. Yuhan-Kimberly's Chungju plant, the first in Korea to acquire the quasi-drug GMP, announced that it operates as a specialized production base for women's products, implementing smart manufacturing to manage quality and processes in real time. The quasi-drug GMP is a manufacturing and quality control standard for quasi-drugs recognized by the Ministry of Food and Drug Safety. Photo credit: Yuhan-Kimberly

This content was produced with the assistance of AI translation services.